Paderanga, Carmelo, JR.. L.

HRN: 25-95-51  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/14/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/14/2025
04/23/2025
IVTT
500 Mg
Q6
Tetanus Infection
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: